About UsDedicated to be an exquisite specialized pharmaceutical research company
Beijing Wista Pharma Co., Ltd, founded in 2009, is located in Beijing Economic-Technological Development Area, committed to independent research and authorized production for chemical innovative drugs and high-end generic drugs.
Our laboratory area is more than 2000 square meters, which has passed the environmental assessment, fire protection and safety assessment in Beijing, is equipped with a series of precise instruments, like, high performance liquid chromatograph, gas chromatograph, ion chromatography, dissolution tester (manual, automatic), ultraviolet spectrophotometer, atomic absorption, ICP-MS, HPLC-MS, GC-MS, automatic amino acid analyzer (Germany), high-speed tablet press, wet & dry granulator machine, multidimensional mixer, boiling granulator & coating dryer, coating machine, freeze dryer , homogenizer, filling machine, osmotic pressure tester, Particle measuring systems, laser particle size analyzer, powder tester, etc.
Dedicated to be an exquisite specialized pharmaceutical research company
Agent & registration service for imported drugs
Agent & registration service for imported drugs:Quality system assessment for registered factory, DMF document translation & sorting (M4 format), technical docume...
Consistency evaluation of special preparation
Consistency evaluation of special preparation:The manufacturing process research, quality research & pilot scaling-up test, manufacturing process & MOA transfer, process ...
Study on special preparation formulation and process technol
Study on special preparation formulation and process technology:The formulation, process development & manu-tech transfer of enteric-coated preparation (delayed release),...
Study on the quality of chemical drugs
Study on the quality of chemical drugs:The quality research of chemical drugs that meet the requirements of drug registration, including the establishment & validation of...
Customized services for drug impurity reference
Customized services for drug impurity reference:In the process of drug development and registration, impurity study is an important part of quality research, which is dir...
Genotoxic impurity:Identification & determination of genotoxic impurity, genotoxic impurity classification, genotoxic impurity limit control method & validation, ...
- Company News |
- Company News
Luliconazole and posaconazole are launched into market
The synthesis pilots of Luliconazole and posaconazole are successfully completed.The key intermediates are available to international market from July 2013.
Olopatadine hydrochloride tablets has been approved by China SF
Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and ...
Voriconazole tablets has been approved by China SF
Our new formulation Voriconazole tablets (50mg and 200mg) has been approved by China SFDA on 24th Nov. 2021. The tablets registration certificate No. is H20213892 and H20...
Center for Drug Evaluation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and
Issues Pertaining to ImpleCenter for Drug Evaluation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and Technical Review
NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs
NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs As per the requirements of the Notice of the General Office of the State Counci...